Annual Working Capital
$1.11 B
-$275.31 M-19.83%
31 December 2023
Summary:
Royalty Pharma annual working capital is currently $1.11 billion, with the most recent change of -$275.31 million (-19.83%) on 31 December 2023. During the last 3 years, it has fallen by -$1.28 billion (-53.42%). RPRX annual working capital is now -58.89% below its all-time high of $2.71 billion, reached on 31 December 2021.RPRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$626.44 M
-$1.68 B-72.80%
30 September 2024
Summary:
Royalty Pharma quarterly working capital is currently $626.44 million, with the most recent change of -$1.68 billion (-72.80%) on 30 September 2024. Over the past year, it has dropped by -$974.24 million (-60.86%). RPRX quarterly working capital is now -81.14% below its all-time high of $3.32 billion, reached on 30 June 2022.RPRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.8% | -60.9% |
| 3 y3 years | -53.4% | -75.2% |
| 5 y5 years | -45.1% | - |
RPRX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -58.9% | at low | -81.1% | at low |
| 5 y | 5 years | -58.9% | +123.2% | -81.1% | +25.6% |
| alltime | all time | -58.9% | +123.2% | -81.1% | +25.6% |
Royalty Pharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $626.44 M(-72.8%) |
| June 2024 | - | $2.30 B(+60.5%) |
| Mar 2024 | - | $1.44 B(+29.0%) |
| Dec 2023 | $1.11 B(-19.8%) | $1.11 B(-30.5%) |
| Sept 2023 | - | $1.60 B(-10.1%) |
| June 2023 | - | $1.78 B(+17.6%) |
| Mar 2023 | - | $1.51 B(+9.1%) |
| Dec 2022 | $1.39 B | $1.39 B(+14.7%) |
| Sept 2022 | - | $1.21 B(-63.6%) |
| June 2022 | - | $3.32 B(+16.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.85 B(+5.2%) |
| Dec 2021 | $2.71 B(+13.3%) | $2.71 B(+7.4%) |
| Sept 2021 | - | $2.52 B(+4.0%) |
| June 2021 | - | $2.42 B(+12.2%) |
| Mar 2021 | - | $2.16 B(-9.6%) |
| Dec 2020 | $2.39 B(+379.1%) | $2.39 B(-5.0%) |
| Sept 2020 | - | $2.51 B(-14.5%) |
| June 2020 | - | $2.94 B(+125.5%) |
| Mar 2020 | - | $1.30 B(+161.5%) |
| Dec 2019 | $498.65 M(-75.4%) | $498.65 M |
| Dec 2018 | $2.03 B | - |
FAQ
- What is Royalty Pharma annual working capital?
- What is the all time high annual working capital for Royalty Pharma?
- What is Royalty Pharma annual working capital year-on-year change?
- What is Royalty Pharma quarterly working capital?
- What is the all time high quarterly working capital for Royalty Pharma?
- What is Royalty Pharma quarterly working capital year-on-year change?
What is Royalty Pharma annual working capital?
The current annual working capital of RPRX is $1.11 B
What is the all time high annual working capital for Royalty Pharma?
Royalty Pharma all-time high annual working capital is $2.71 B
What is Royalty Pharma annual working capital year-on-year change?
Over the past year, RPRX annual working capital has changed by -$275.31 M (-19.83%)
What is Royalty Pharma quarterly working capital?
The current quarterly working capital of RPRX is $626.44 M
What is the all time high quarterly working capital for Royalty Pharma?
Royalty Pharma all-time high quarterly working capital is $3.32 B
What is Royalty Pharma quarterly working capital year-on-year change?
Over the past year, RPRX quarterly working capital has changed by -$974.24 M (-60.86%)